Evidence map›Paper›PMID 29719779›Full record

ArticleActa pharmaceutica Sinica. B2018

A pilot study of the modulation of sirtuins on arylamine

Eneida Turiján-Espinoza, Rául Alejandro Salazar-González, Edith Elena Uresti-Rivera, Gloria Estela Hernández-Hernández, Montserrat Ortega-Juárez, Rosa Milán, Diana Portales-Pérez

Open access · diamondAbstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. ArylamineFrontiers in pharmacology · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Eneida Turiján-EspinozaLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Rául Alejandro Salazar-GonzálezLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Edith Elena Uresti-RiveraLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Gloria Estela Hernández-HernándezLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Montserrat Ortega-JuárezLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Rosa MilánLaboratory of Biopharmacy and Pharmacokinetics, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Diana Portales-PérezLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Science, UASLP, San Luis Potosi, Mexico.
Autonomous University of San Luis Potosí · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arylamine

Indexed as

Ac-INH, acetyl-IsoniazidAc-PABA, acetyl-p-aminobenzoic acidAPC, allophycocyaninArylamine N-acetyltransferaseCHO, Chinese hamster ovary cellsDMEM, Dulbecco's modified Eagle's mediumE2F1, E2F transctriptios factor 1ER81, ETS-related protein 81FITC, fluorescein IsoTioCyanateFOXO1, forkhead box protein O1HeLa, adenocarcinoma epithelial cellsHPLC, high performance liquid chromatographyINH, isoniazidNAD, nicotinamide adenine dinucleotideNAM, nicotinamideNATNAT, arylamine N-acetyltranferaseNicotinamidePABA, p-aminobenzoic acidPAS, p-aminosalicilic acidPBMC, peripheral blood mononuclear cellsPBS, phosphate-buffered salinePeripheral blood mononuclear cellsPGAM1, phosphoglycerate mutase 1PGC-1α, peroxisome proliferator-activated receptor-gamma coactivator 1αResveratrolRSV, resveratrolRUNX3, runt-related transcription factor 3SIRT, sirtuinSirtuinsSMZ, sulfamethazineSREBP1a, sterol regulatory element-binding protein 1aSREBP2, sterol regulatory element-binding protein 2

Identifiers

PMID29719779
PMCPMC5926248
OpenAlexW2775932018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.